Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Action of the Amantadine on Post Stroke Aphasic Patients' Language and Communication

NCT00821691 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT00821691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00821691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Action of the Amantadine on Post Stroke Aphasic Patients' Language and Communication
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2009
Completion date
April 30, 2013
Enrollment
50 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction